TOMSICEK MICHAEL JOHN 4
4 · Acrivon Therapeutics, Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
TOMSICEK MICHAEL JOHN
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-20+20,275→ 20,275 totalExercise: $6.52Exp: 2034-06-19→ Common Stock (20,275 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date.